Active, not recruitingEarly Phase 1NCT05091866

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Hui-Kuo G Shu, MD, PhD, FASTRO
Emory University Hospital/Winship Cancer Institute
Intervention
Quality-of-Life Assessment(other)
Enrollment
4 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2027

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05091866 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials